Homozygous deletion of the entire AAAS gene in a triple A syndrome patient

Eur J Med Genet. 2019 Jul;62(7):103665. doi: 10.1016/j.ejmg.2019.05.004. Epub 2019 May 6.

Abstract

Triple A syndrome, a multisystemic autosomal recessive disease, is characterized by the clinical triad of adrenal insufficiency, alacrima and achalasia in combination with progressive neurological impairments. The disorder is caused by homozygous or compound heterozygous mutations in the AAAS gene. Here we present the clinical and molecular data of a ten year old patient with triple A syndrome. Array CGH analysis confirmed the PCR-based assumption of a homozygous deletion of the entire AAAS gene in the patient and a heterozygous deletion in both parents. We demonstrate that the patient carries a 15 kb deletion and identified the 5' and 3' breakpoints outside the AAAS gene. This is the first report of a triple A syndrome patient with a homozygous deletion of the entire AAAS gene.

Keywords: Achalasia; Adrenal insufficiency; Alacrima; Gene deletion; Triple A syndrome.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Insufficiency / genetics*
  • Adrenal Insufficiency / pathology
  • Adult
  • Child
  • Child, Preschool
  • Esophageal Achalasia / genetics*
  • Esophageal Achalasia / pathology
  • Gene Deletion*
  • Homozygote
  • Humans
  • Male
  • Nerve Tissue Proteins / genetics*
  • Nuclear Pore Complex Proteins / genetics*
  • Pedigree

Substances

  • AAAS protein, human
  • Nerve Tissue Proteins
  • Nuclear Pore Complex Proteins

Supplementary concepts

  • Achalasia Addisonianism Alacrimia syndrome